KCM
IBB icon

Karp Capital Management’s iShares Biotechnology ETF IBB Stock Holding History

Karp Capital Management’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-21,536
Closed -$2.52M – 42
2022
Q3 		$2.52M Buy
+21,536
New +$2.67M 0.52% 50
2019
Q2 		– Sell
-45,624
Closed -$5.1M – 108
2019
Q1 		$5.1M Buy
45,624
+1,280
+3% +$140K 1.81% 16
2018
Q4 		$4.28M Sell
44,344
-712
-2% -$75.6K 2.04% 14
2018
Q3 		$5.49M Sell
45,056
-565
-1% -$66.5K 1.89% 13
2018
Q2 		$5.01M Buy
45,621
+680
+2% +$72.7K 1.97% 14
2018
Q1 		$4.8M Buy
44,941
+2,470
+6% +$274K 1.93% 13
2017
Q4 		$4.54M Buy
42,471
+2,811
+7% +$300K 1.92% 13
2017
Q3 		$4.41M Buy
39,660
+2,265
+6% +$242K 2.05% 11
2017
Q2 		$3.87M Buy
37,395
+6,600
+21% +$650K 1.91% 15
2017
Q1 		$3.01M Buy
30,795
+5,037
+20% +$482K 1.7% 25
2016
Q4 		$2.28M Sell
25,758
-810
-3% -$73.7K 1.5% 30
2016
Q3 		$2.56M Buy
26,568
+12,885
+94% +$1.23M 1.64% 24
2016
Q2 		$1.17M Sell
13,683
-525
-4% -$47.1K 0.78% 51
2016
Q1 		$1.24M Sell
14,208
-2,340
-14% -$209K 0.85% 53
2015
Q4 		$1.87M Buy
16,548
+13,170
+390% +$1.43M 1.08% 39
2015
Q3 		$342K Buy
3,378
+2,175
+181% +$261K 0.23% 71
2015
Q2 		$148K Buy
1,203
+240
+25% +$28.7K 0.1% 107
2015
Q1 		$110K Buy
963
+225
+30% +$24.8K 0.07% 129
2014
Q4 		$75K Buy
+738
New +$71.7K 0.05% 144

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AWA
Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
CANY
Caxton Associates (New York) New York $3.18B AUM 54.49% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Karp Capital Management's IBB Position: Q4 2022 in Review

Karp Capital Management sold out of iShares Biotechnology ETF (IBB) in Q4 2022, closing a stake of 21,536 shares — an estimated $2.52M sold.

Karp Capital Management first reported a position in IBB in Q4 2014 and held it in 19 quarters. The position peaked at $5.49M in Q3 2018. 902 funds tracked by Wall St. Rank hold IBB as of Q4 2022.

  • Karp Capital Management reported no remaining iShares Biotechnology ETF position as of Q4 2022 after selling out during the quarter.
  • Karp Capital Management sold 21,536 iShares Biotechnology ETF shares in Q4 2022, an estimated $2.52M.
  • Karp Capital Management first reported a position in iShares Biotechnology ETF in Q4 2014 and held it in 19 quarters.
  • Karp Capital Management's iShares Biotechnology ETF position peaked at $5.49M in Q3 2018.
  • 902 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2022.

Based on Karp Capital Management's 13F filing for Q4 2022.